Extrahepatic Complications of Hepatitis C Virus Infection in HIV and the Impact of Successful Antiviral Treatment

被引：3
作者：
Lo Re, Vincent, III [1 ,2 ]
机构：
[1] Penn Ctr Viral Hepatitis, Penn Ctr AIDS Res, Dept Med, Div Infect Dis, Philadelphia, PA USA
[2] Univ Penn, Ctr Pharmacoepidemiol Res & Training, Dept Biostat & Epidemiol, Ctr Clin Epidemiol & Biostat,Perelman Sch Med, Philadelphia, PA 19104 USA
来源：
CLINICAL INFECTIOUS DISEASES | 2017年 / 64卷 / 04期
关键词：
hepatitis C; HIV; extrahepatic; diabetes; SUSTAINED VIROLOGICAL RESPONSE; INSULIN-RESISTANCE; REDUCES INCIDENCE; OPEN-LABEL; HCV; MORTALITY; RISK; THERAPY; COHORT; SOFOSBUVIR;
D O I：
10.1093/cid/ciw814
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：498 / 500
页数：3
相关论文
共 30 条
  • [1] Sustained Virological Response Reduces Incidence of Onset of Type 2 Diabetes in Chronic Hepatitis C
    Arase, Yasuji
    Suzuki, Fumitaka
    Suzuki, Yoshiyuki
    Akuta, Norio
    Kobayashi, Masahiro
    Kawamura, Yusuke
    Yatsuji, Hiromi
    Sezaki, Hitomi
    Ilosaka, Tetsuya
    Hirakawa, Miharu
    Ikeda, Kenji
    Kumada, Hiromitsu
    [J]. HEPATOLOGY, 2009, 49 (03) : 739 - 744
  • [2] Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States
    Barua, Soumitri
    Greenwald, Robert
    Grebely, Jason
    Dore, Gregory J.
    Swan, Tracy
    Taylor, Lynn E.
    [J]. ANNALS OF INTERNAL MEDICINE, 2015, 163 (03) : 215 - +
  • [3] Sustained Virological Response to Interferon Plus Ribavirin Reduces Non-Liver-Related Mortality in Patients Coinfected With HIV and Hepatitis C Virus
    Berenguer, Juan
    Rodriguez, Elena
    Miralles, Pilar
    Von Wichmann, Miguel A.
    Lopez-Aldeguer, Jose
    Mallolas, Josep
    Galindo, Maria J.
    Van Den Eynde, Eva
    Tellez, Maria J.
    Quereda, Carmen
    Jou, Antoni
    Sanz, Jose
    Barros, Carlos
    Santos, Ignacio
    Pulido, Federico
    Guardiola, Josep M.
    Ortega, Enrique
    Rubio, Rafael
    Jusdado, Juan J.
    Montes, Maria L.
    Gaspar, Gabriel
    Esteban, Herminia
    Bellon, Jose M.
    Gonzalez-Garcia, Juan
    [J]. CLINICAL INFECTIOUS DISEASES, 2012, 55 (05) : 728 - 736
  • [4] Limited Access to New Hepatitis C Virus Treatment Under State Medicaid Programs
    Canary, Lauren A.
    Klevens, R. Monina
    Holmberg, Scott D.
    [J]. ANNALS OF INTERNAL MEDICINE, 2015, 163 (03) : 226 - +
  • [5] The Risk of Incident Coronary Heart Disease Among Veterans With and Without HIV and Hepatitis C
    Freiberg, Matthew S.
    Chang, Chung-Chou H.
    Skanderson, Melissa
    McGinnis, Kathleen
    Kuller, Lewis H.
    Kraemer, Kevin L.
    Rimland, David
    Goetz, Matthew B.
    Butt, Adeel A.
    Barradas, Maria C. Rodriguez
    Gibert, Cynthia
    Leaf, David
    Brown, Sheldon T.
    Samet, Jeffrey
    Kazis, Lewis
    Bryant, Kendall
    Justice, Amy C.
    [J]. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2011, 4 (04): : 425 - 432
  • [6] Long-Term Effect of HCV Eradication in Patients With Mixed Cryoglobulinemia: A Prospective, Controlled, Open-Label, Cohort Study
    Gragnani, Laura
    Fognani, Elisa
    Piluso, Alessia
    Boldrini, Barbara
    Urraro, Teresa
    Fabbrizzi, Alessio
    Stasi, Cristina
    Ranieri, Jessica
    Monti, Monica
    Arena, Umberto
    Iannacone, Claudio
    Laffi, Giacomo
    Zignego, Anna Linda
    [J]. HEPATOLOGY, 2015, 61 (04) : 1145 - 1153
  • [7] Fracture risk in hepatitis C virus infected persons: Results from the DANVIR cohort study
    Hansen, Ann-Brit Eg
    Omland, Lars Haukali
    Krarup, Henrik
    Obel, Niels
    [J]. JOURNAL OF HEPATOLOGY, 2014, 61 (01) : 15 - 21
  • [8] The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis C
    Hassanein, T
    Cooksley, G
    Sulkowski, M
    Smith, C
    Marinos, G
    Lai, MY
    Pastore, G
    Trejo-Estrada, R
    Vale, AHE
    Wintfeld, N
    Green, J
    [J]. JOURNAL OF HEPATOLOGY, 2004, 40 (04) : 675 - 681
  • [9] Interferon-based therapy reduces risk of stroke in chronic hepatitis C patients: a population-based cohort study in Taiwan
    Hsu, C-S
    Kao, J-H
    Chao, Y-C
    Lin, H. H.
    Fan, Y-C
    Huang, C-J
    Tsai, P-S
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 38 (04) : 415 - 423
  • [10] Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2
    Kawaguchi, Takumi
    Ide, Tatsuya
    Taniguchi, Eitaro
    Hirano, Eiichi
    Itou, Minoru
    Sumie, Shuji
    Nagao, Yumiko
    Yanagimoto, Chikatoshi
    Hanada, Shinichiro
    Koga, Hironori
    Sata, Michio
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (03) : 570 - 576
123